nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE3A—penis—metabolic syndrome X	0.212	0.383	CbGeAlD
Tofisopam—PDE2A—cardiovascular system—metabolic syndrome X	0.0598	0.108	CbGeAlD
Tofisopam—PDE10A—adipose tissue—metabolic syndrome X	0.0527	0.0954	CbGeAlD
Tofisopam—PDE2A—adipose tissue—metabolic syndrome X	0.0527	0.0954	CbGeAlD
Tofisopam—PDE2A—liver—metabolic syndrome X	0.037	0.0669	CbGeAlD
Tofisopam—PDE4A—adipose tissue—metabolic syndrome X	0.0363	0.0657	CbGeAlD
Tofisopam—PDE3A—cardiovascular system—metabolic syndrome X	0.034	0.0616	CbGeAlD
Tofisopam—PDE3A—adipose tissue—metabolic syndrome X	0.03	0.0543	CbGeAlD
Tofisopam—PDE3A—liver—metabolic syndrome X	0.021	0.0381	CbGeAlD
Tofisopam—CYP3A4—kidney—metabolic syndrome X	0.0107	0.0193	CbGeAlD
Tofisopam—CYP3A4—liver—metabolic syndrome X	0.00675	0.0122	CbGeAlD
Tofisopam—PDE2A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00271	0.00606	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00264	0.0059	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00257	0.00575	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00246	0.0055	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00243	0.00544	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—APOA1—metabolic syndrome X	0.00242	0.00541	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.0024	0.00535	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IGF2—metabolic syndrome X	0.00239	0.00533	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00233	0.00522	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—APOB—metabolic syndrome X	0.00232	0.00518	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00229	0.00513	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PLA2G4A—metabolic syndrome X	0.00225	0.00504	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00221	0.00494	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—CD36—metabolic syndrome X	0.0021	0.0047	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HDAC3—metabolic syndrome X	0.00209	0.00467	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00205	0.00459	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IGF1—metabolic syndrome X	0.00202	0.00452	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00195	0.00435	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SERPINE1—metabolic syndrome X	0.00192	0.00429	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—metabolic syndrome X	0.00192	0.00428	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00189	0.00422	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00187	0.00417	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00187	0.00417	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00184	0.00412	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS3—metabolic syndrome X	0.00183	0.0041	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—APOA1—metabolic syndrome X	0.00183	0.0041	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00182	0.00407	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RBP4—metabolic syndrome X	0.00182	0.00407	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00177	0.00395	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00177	0.00395	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00174	0.0039	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.00171	0.00383	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00171	0.00381	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00168	0.00374	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOC3—metabolic syndrome X	0.00161	0.0036	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.0016	0.00357	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00159	0.00355	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HDAC3—metabolic syndrome X	0.00158	0.00354	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00158	0.00353	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00155	0.00347	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00155	0.00347	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IGF1—metabolic syndrome X	0.00153	0.00343	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SERPINE1—metabolic syndrome X	0.00146	0.00325	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00145	0.00325	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—metabolic syndrome X	0.00145	0.00325	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00145	0.00324	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGT—metabolic syndrome X	0.00143	0.0032	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00143	0.0032	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00141	0.00316	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00141	0.00316	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CYBA—metabolic syndrome X	0.00141	0.00315	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF2—metabolic syndrome X	0.00141	0.00314	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS3—metabolic syndrome X	0.00139	0.00311	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—GHRL—metabolic syndrome X	0.00138	0.00308	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00138	0.00308	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RBP4—metabolic syndrome X	0.00138	0.00308	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—APOB—metabolic syndrome X	0.00137	0.00305	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PLA2G4A—metabolic syndrome X	0.00133	0.00297	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00131	0.00294	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CNR1—metabolic syndrome X	0.00131	0.00292	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCL5—metabolic syndrome X	0.0013	0.0029	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00129	0.00289	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00124	0.00278	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CD36—metabolic syndrome X	0.00124	0.00277	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOC3—metabolic syndrome X	0.00122	0.00273	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—metabolic syndrome X	0.00121	0.00271	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00121	0.00271	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGT—metabolic syndrome X	0.0012	0.00267	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00118	0.00264	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00118	0.00264	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00115	0.00257	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00113	0.00253	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00112	0.0025	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HTR2C—metabolic syndrome X	0.0011	0.00246	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.0011	0.00246	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00109	0.00243	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGT—metabolic syndrome X	0.00109	0.00243	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—APOA1—metabolic syndrome X	0.00108	0.00241	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00107	0.0024	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF2—metabolic syndrome X	0.00107	0.00239	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CYBA—metabolic syndrome X	0.00107	0.00239	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GHRL—metabolic syndrome X	0.00104	0.00234	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00104	0.00233	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOB—metabolic syndrome X	0.00104	0.00232	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00101	0.00227	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL5—metabolic syndrome X	0.00101	0.00226	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00101	0.00225	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LPL—metabolic syndrome X	0.00099	0.00221	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CNR1—metabolic syndrome X	0.00099	0.00221	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000987	0.00221	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000959	0.00214	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000933	0.00209	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—metabolic syndrome X	0.000919	0.00205	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF1—metabolic syndrome X	0.000903	0.00202	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000894	0.002	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000866	0.00194	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SERPINE1—metabolic syndrome X	0.000858	0.00192	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000857	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—metabolic syndrome X	0.000856	0.00191	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGT—metabolic syndrome X	0.000847	0.00189	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000843	0.00188	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—AKT1—metabolic syndrome X	0.000843	0.00188	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RBP4—metabolic syndrome X	0.000835	0.00187	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000835	0.00187	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000834	0.00186	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOE—metabolic syndrome X	0.000829	0.00185	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LEP—metabolic syndrome X	0.000829	0.00185	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOA1—metabolic syndrome X	0.00082	0.00183	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS3—metabolic syndrome X	0.000819	0.00183	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000813	0.00182	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RBP4—metabolic syndrome X	0.000813	0.00182	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF2—metabolic syndrome X	0.000809	0.00181	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000787	0.00176	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOB—metabolic syndrome X	0.000785	0.00176	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000784	0.00175	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL5—metabolic syndrome X	0.000767	0.00171	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000765	0.00171	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000764	0.00171	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000762	0.0017	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LPL—metabolic syndrome X	0.00075	0.00168	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IRS1—metabolic syndrome X	0.00074	0.00165	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOC3—metabolic syndrome X	0.00074	0.00165	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000725	0.00162	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOC3—metabolic syndrome X	0.00072	0.00161	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—INS—metabolic syndrome X	0.000709	0.00158	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000705	0.00158	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL2—metabolic syndrome X	0.000697	0.00156	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF1—metabolic syndrome X	0.000685	0.00153	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000668	0.00149	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGT—metabolic syndrome X	0.000658	0.00147	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000651	0.00145	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00065	0.00145	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CYBA—metabolic syndrome X	0.000647	0.00145	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGT—metabolic syndrome X	0.000642	0.00143	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGT—metabolic syndrome X	0.00064	0.00143	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—AKT1—metabolic syndrome X	0.000639	0.00143	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GHRL—metabolic syndrome X	0.000633	0.00142	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CYBA—metabolic syndrome X	0.000629	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOE—metabolic syndrome X	0.000629	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LEP—metabolic syndrome X	0.000629	0.00141	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOS3—metabolic syndrome X	0.000621	0.00139	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOA1—metabolic syndrome X	0.000621	0.00139	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GHRL—metabolic syndrome X	0.000616	0.00138	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000607	0.00136	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CNR1—metabolic syndrome X	0.0006	0.00134	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CNR1—metabolic syndrome X	0.000583	0.0013	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IRS1—metabolic syndrome X	0.000561	0.00125	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000542	0.00121	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—metabolic syndrome X	0.000541	0.00121	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—INS—metabolic syndrome X	0.000537	0.0012	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000533	0.00119	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL2—metabolic syndrome X	0.000528	0.00118	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000527	0.00118	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—metabolic syndrome X	0.000524	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF1—metabolic syndrome X	0.000519	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000493	0.0011	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF2—metabolic syndrome X	0.00049	0.0011	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000484	0.00108	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF2—metabolic syndrome X	0.000477	0.00107	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOB—metabolic syndrome X	0.000476	0.00106	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOS3—metabolic syndrome X	0.000471	0.00105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL5—metabolic syndrome X	0.000465	0.00104	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000463	0.00103	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOB—metabolic syndrome X	0.000463	0.00103	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	0.000454	0.00102	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL5—metabolic syndrome X	0.000452	0.00101	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00045	0.00101	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LPL—metabolic syndrome X	0.000442	0.000988	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000411	0.000919	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000404	0.000902	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—metabolic syndrome X	0.000397	0.000888	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	0.000389	0.000869	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	0.000381	0.000851	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	0.000381	0.000851	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGT—metabolic syndrome X	0.000378	0.000845	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	0.000377	0.000842	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—AKT1—metabolic syndrome X	0.000376	0.000841	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOE—metabolic syndrome X	0.00037	0.000828	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LEP—metabolic syndrome X	0.00037	0.000828	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000366	0.000819	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOA1—metabolic syndrome X	0.000366	0.000819	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	0.00034	0.000759	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IRS1—metabolic syndrome X	0.000331	0.000739	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—INS—metabolic syndrome X	0.000325	0.000727	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	0.00032	0.000716	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—INS—metabolic syndrome X	0.000317	0.000708	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	0.000315	0.000704	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL2—metabolic syndrome X	0.000311	0.000696	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000311	0.000696	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—metabolic syndrome X	0.00031	0.000692	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—metabolic syndrome X	0.000306	0.000684	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000302	0.000676	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000299	0.000668	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000291	0.00065	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AKT1—metabolic syndrome X	0.000286	0.000639	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	0.000285	0.000638	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—metabolic syndrome X	0.000278	0.00062	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000269	0.000602	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000269	0.000602	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000253	0.000566	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000245	0.000547	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	0.000241	0.000538	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000238	0.000532	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—metabolic syndrome X	0.000235	0.000525	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—metabolic syndrome X	0.000234	0.000523	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000222	0.000496	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AKT1—metabolic syndrome X	0.000216	0.000484	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000216	0.000483	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000215	0.000481	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000204	0.000456	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000189	0.000422	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000184	0.00041	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000182	0.000407	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000178	0.000397	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000174	0.000388	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000174	0.000388	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000168	0.000376	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000166	0.000372	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	0.000155	0.000346	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	0.000142	0.000318	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	0.000139	0.00031	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—metabolic syndrome X	0.000138	0.000309	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LIPC—metabolic syndrome X	0.000138	0.000308	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCK—metabolic syndrome X	0.000138	0.000308	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOC3—metabolic syndrome X	0.000137	0.000306	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CETP—metabolic syndrome X	0.000133	0.000297	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	0.000131	0.000293	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT1—metabolic syndrome X	0.000128	0.000285	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	0.000127	0.000285	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	0.000124	0.000276	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	0.00012	0.000269	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GOT2—metabolic syndrome X	0.00012	0.000269	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	0.000107	0.00024	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	0.000107	0.00024	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GOT1—metabolic syndrome X	0.000104	0.000232	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GGT1—metabolic syndrome X	0.000104	0.000232	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOB—metabolic syndrome X	8.81e-05	0.000197	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	8.57e-05	0.000192	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LPL—metabolic syndrome X	8.42e-05	0.000188	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CD36—metabolic syndrome X	8e-05	0.000179	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARA—metabolic syndrome X	7.43e-05	0.000166	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AGT—metabolic syndrome X	7.2e-05	0.000161	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOE—metabolic syndrome X	7.05e-05	0.000158	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOA1—metabolic syndrome X	6.97e-05	0.000156	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.14e-05	0.000137	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—INS—metabolic syndrome X	6.03e-05	0.000135	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—metabolic syndrome X	5.52e-05	0.000123	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.28e-05	0.000118	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.83e-05	0.000108	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.43e-05	5.43e-05	CbGpPWpGaD
